Why Submit to JATS

JATS provides a focused platform for therapeutic science research that connects preclinical innovation with clinical development, pharmacology, and translational medicine. Our editorial scope covers small molecules, biologics, gene and cell therapies, drug delivery, precision therapeutics, and outcomes evidence.

We value clear mechanistic insight, robust study design, and conclusions that improve therapeutic decision making, development pipelines, and patient outcomes.

We publish original research, reviews, short communications, methods, and data rich studies that advance therapeutic science knowledge. Manuscripts receive expert handling by editors and reviewers who understand the rigor needed for preclinical validation, clinical trials, translational studies, and real world outcomes reporting.

We welcome collaborative studies that bridge laboratory discovery with clinical decision making and long term patient outcomes.

Open access publication ensures rapid visibility, global readership, and practical impact. For authors seeking to maximize citations, funder compliance, and research reuse, JATS offers clear scope alignment and a professional publishing experience.

Manuscript Readiness and Research Quality

Strong JATS submissions present a clear clinical or mechanistic hypothesis, rigorous methods, and transparent reporting. Whether you are describing preclinical models, clinical trials, observational cohorts, registries, or translational studies, we recommend clear study design statements and complete methodological detail so reviewers can evaluate reproducibility.

Figures and tables should communicate outcomes with precision. Use high resolution images, report sample sizes, effect sizes, and statistical tests, and include appropriate controls. Data availability statements should describe repositories, accession numbers, or how readers can access supporting datasets.

For studies involving human participants, biospecimens, or animal models, include ethics approval identifiers and compliance statements. We also welcome pre registered studies and encourage structured reporting standards when available for your research area.

Editorial Workflow and Visibility

After submission, manuscripts receive an editorial assessment and are assigned to subject editors for peer review. Our goal is to deliver a timely first decision while maintaining rigorous evaluation standards.

Accepted articles are professionally produced in HTML, PDF, and XML formats and are integrated with DOI registration and indexing metadata. This ensures your work is discoverable through academic search engines and citation networks.

Authors receive clear status updates at key stages, and revision guidance focuses on scientific clarity, data integrity, and therapeutic science significance. Once published, articles are promoted through journal channels to increase visibility across academic, clinical, and industry audiences.

JATS welcomes thematic special issues in emerging therapeutic science areas. If you are organizing a research community or conference track, contact us about proposing a special issue or serving as a guest editor.